SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000556
Filing Date
2022-03-28
Accepted
2022-03-28 08:23:45
Documents
53
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ckpt-20211231x10k.htm   iXBRL 10-K 1479420
2 EX-4.3 ckpt-20211231xex4d3.htm EX-4.3 58836
3 EX-23.1 ckpt-20211231xex23d1.htm EX-23.1 5262
4 EX-31.1 ckpt-20211231xex31d1.htm EX-31.1 11070
5 EX-31.2 ckpt-20211231xex31d2.htm EX-31.2 10967
6 EX-32.1 ckpt-20211231xex32d1.htm EX-32.1 5770
7 EX-32.2 ckpt-20211231xex32d2.htm EX-32.2 5811
  Complete submission text file 0001410578-22-000556.txt   5216640

Data Files

Seq Description Document Type Size
8 EX-101.SCH ckpt-20211231.xsd EX-101.SCH 40178
9 EX-101.CAL ckpt-20211231_cal.xml EX-101.CAL 32929
10 EX-101.DEF ckpt-20211231_def.xml EX-101.DEF 168658
11 EX-101.LAB ckpt-20211231_lab.xml EX-101.LAB 294057
12 EX-101.PRE ckpt-20211231_pre.xml EX-101.PRE 259505
47 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20211231x10k_htm.xml XML 717790
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 22773280
SIC: 2834 Pharmaceutical Preparations